In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. Earlier in the week, the number of deaths stood at two people.